ARTICLE | Clinical News
MethyPatch: Began Phase III trial
October 16, 2000 7:00 AM UTC
Noven Pharmaceuticals Inc. (NOVN), Miami, Fla. Product: MethyPatch Business: Neurological, Drug delivery Therapeutic category: Neurotransmission Target: Brain stem and cortex Description: Once per day...